GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Cyclically Adjusted PB Ratio

Cangene (FRA:YGE) Cyclically Adjusted PB Ratio : (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Cangene Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cangene Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cangene's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Cyclically Adjusted PB Ratio Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Cangene's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Cangene's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cangene's Cyclically Adjusted PB Ratio falls into.



Cangene Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cangene's Cyclically Adjusted Book per Share for the quarter that ended in Oct. 2013 is calculated as:

For example, Cangene's adjusted Book Value per Share data for the three months ended in Oct. 2013 was:

Adj_Book=Book Value per Share/CPI of Oct. 2013 (Change)*Current CPI (Oct. 2013)
=2.106/97.1820*97.1820
=2.106

Current CPI (Oct. 2013) = 97.1820.

Cangene Quarterly Data

Book Value per Share CPI Adj_Book
200401 1.347 81.617 1.604
200404 1.455 82.249 1.719
200407 1.359 82.960 1.592
200410 1.645 83.118 1.923
200501 1.568 83.197 1.832
200504 1.576 84.224 1.818
200507 0.936 84.619 1.075
200510 1.612 85.252 1.838
200601 1.701 85.489 1.934
200604 1.794 86.279 2.021
200607 1.724 86.595 1.935
200610 1.824 86.121 2.058
200701 1.978 86.437 2.224
200704 1.978 88.175 2.180
200707 2.226 88.491 2.445
200710 2.259 88.175 2.490
200801 2.100 88.333 2.310
200804 1.982 89.676 2.148
200807 2.104 91.493 2.235
200810 2.323 90.466 2.495
200901 2.311 89.281 2.516
200904 2.501 89.992 2.701
200907 2.799 90.624 3.002
200910 2.698 90.545 2.896
201001 2.865 90.940 3.062
201004 3.247 91.651 3.443
201007 2.578 92.283 2.715
201010 3.025 92.757 3.169
201101 2.463 93.074 2.572
201104 2.262 94.654 2.322
201107 2.401 94.812 2.461
201110 2.388 95.444 2.431
201201 2.498 95.365 2.546
201204 2.399 96.550 2.415
201207 2.382 95.997 2.411
201210 2.309 96.550 2.324
201301 2.216 95.839 2.247
201304 2.307 96.945 2.313
201307 2.254 97.261 2.252
201310 2.106 97.182 2.106

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cangene  (FRA:YGE) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cangene Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cangene's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines